Case of bullous pemphigoid associated with teneligliptin accompanied by severe mucous membrane involvement

J Dermatol. 2018 Jul;45(7):e205-e206. doi: 10.1111/1346-8138.14237. Epub 2018 Jan 30.

Authors

Yuta Kage¹, Yukie Yamaguchi², Takahisa Uchida¹, Kentaro Izumi³, Wataru Nishie³, Hiroshi Shimizu³, Norito Ishii⁴, Takashi Hashimoto⁵, Michiko Aihara²

Affiliations

¹ Department of Dermatology, Yokosuka Kyosai Hospital, Yokosuka.
² Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama.
³ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo.
⁴ Department of Dermatology, Kurume University School of Medicine, Kurume.
⁵ Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.

PMID: 29380425
DOI: 10.1111/1346-8138.14237

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Diabetes Mellitus, Type 2 / drug therapy*
Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
Female
Humans
Mucous Membrane / drug effects*
Mucous Membrane / pathology
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / diagnosis
Pemphigoid, Bullous / pathology
Pyrazoles / adverse effects*
Severity of Illness Index
Thiazolidines / adverse effects*

Substances

3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine
Dipeptidyl-Peptidase IV Inhibitors
Pyrazoles
Thiazolidines